Table 2 Histological evaluation of nephrotoxicity following PE-MPs administration.
Lesion type | CNT (control) | 15 mg/kg PE-MPs | 60 mg/kg PE-MPs |
|---|---|---|---|
Glomerular changes (shrinkage, atrophy, sclerosis) | 0 (normal glomeruli, intact Bowman’s spaces) | 1 (mild glomerular shrinkage) | 3 (pronounced atrophy, collapsed glomeruli) |
Tubular alterations (degeneration, dilation, swelling) | 0 (normal tubules) | 1–2 (tubular epithelial cell swelling, mild degeneration) | 3 (severe tubular degeneration and architectural distortion) |
Interstitial inflammation (immune cell infiltration, edema) | 0 (no infiltration) | 1 (occasional inflammatory cells) | 2–3 (dense inflammatory infiltrates, interstitial expansion) |
Overall nephrotoxicity score | 0 (no damage) | 1.5 (mild-to-moderate nephrotoxicity) | 3 (severe nephrotoxicity) |